4 This type of medication was approved by the FDA in 2005 and is generally an injectable delivered in the fatty tissue present just under the skin.4 GLP-1 agonists are prescribed by a doctor who may decide that they are appropriate for an individual based on their specific needs
Recently, the increasing popularity of veganism has lead to many adults becoming deficient in B12
Higher doses slow gastric emptying more aggressively, which means more constipation
doi: 10.1016/S2213-8587(17)30092-X [DOI] [PubMed] [Google Scholar] 70
A few key insights: Patients are actively self-directing care, often sharing detailed dosing protocols and recovery strategies Anecdotal success stories are common, but highly variable and often used to justify self-experimentation There is a clear trend toward DIY medicine and peer-to-peer decision making, sometimes replacing physician guidance Skepticism toward traditional healthcare and regulatory systems is a major driver of adoption Safety concernsincluding side effects, unknown dosing, and product purityare frequently discussed The bigger picture: There is a rapidly widening gap between patient-driven use of peptides and the lack of high-quality clinical evidence guiding their safety and efficacy
Most GLP-1 side effects are mild, gastrointestinal, temporary, and predictable